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Abstract
The research described in this study aimed at developing microemulsions for dermal 
application using avocado oil. Due to its composition, avocado oil helps maintaining the 
barrier function of the skin. It has a nutritional effect on the skin, and it reduces the inten-
sity of the process of skin peeling. Various surfactant:cosurfactant systems were tested 
in the conducted studies. There were no significant differences between the diagrams 
generated by Tween 20 and the surfactant:cosurfactant system, Tween 20:PEG400, at a 
ratio of 1:1. Six formulations were selected from the dilution line 7 of the ternary phase 
diagrams obtained by using as a surfactant Tween 20 and Tween 20:PEG 400, respec-
tively. The formulations were characterized by determining physicochemical properties 
specific. In the next phase of study, these six formulations were used as a vehicle for 
incorporating erythromycin in order to develop erythromicyn incorporated formula-
tions for topical administration. The quality control of microemulsions with erythro-
mycin was performed by evaluating the physical chemical, organoleptic and sensorial 
properties. Microemulsions were pharmacotechnically characterized by assessing the in 
vitro and ex vivo release kinetics of erythromycin.
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1. Introduction
Although microemulsions possess numerous advantages as drug delivery systems, these 
modern pharmaceutical formulations have a limited applicability in the pharmaceutical 
and cosmetic field, due to the quality conditions for raw materials imposed by current leg-
islation. Lately, a special interest has been shown by the specialists of the pharmaceutical 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
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community in formulation and optimization of microemulsions, as an alternative dosage 
form to conventional emulsions and to other delivery systems for various administration 
routes. [1, 2].
Avocado oil is a vegetable oil obtained by cold press extraction from the Persea gratissima tree 
fruit (Lauraceae fam.), and containing a high amount of saturated and unsaturated fatty acids 
and other ingredients such as fat-soluble vitamins, minerals, and oligoelements [3]. Due to 
these bioactive ingredients, avocado oil plays a role in maintaining the skin’s barrier function, 
manifests a nurturing effect on the dermal tissue, and decreases the exfoliation process.
Acne is a common skin condition that affects about 30% of the world’s population, and half of 
whom are patients aged between 30 and 50 years [4]. Topical antibiotic therapy is an integral part 
of the therapeutic process of acne. Erythromycin is a macrolide antibiotic used to treat acne for 
over 20 years [5, 6]. Although some studies have shown the emergence of erythromycin resis-
tance of germs involved in the pathogenesis of acne and the presence of local irritative reactions, 
this antibiotic is still successfully used by dermatologists as the antibiotic of choice for the local 
treatment of this dermatosis [7–10]. Erythromycin for topical use is usually formulated as cream. 
Serdoz et al. studied the incorporation of erythromycin into microemulsions based on mono- and 
triglycerides of medium chain fatty acids using Tween 80 as a surfactant. The obtained results 
showed a doubling of ER bioavailability when it was orally administered as emulsion [11].
The aim of this study was to include erythromycin in microemulsion-based preparations 
obtained with avocado oil and various cosolvent systems designed to increase efficiency and 
skin tolerance to the antibiotic.
2. Materials and methods
2.1. Materials
Avocado oil (Natural Sourcing LLC, Oxford, England), isopropyl myristate (Sigma-Aldrich, 
Germany), polyethylene glycol 400 (Sigma-Aldrich, Germany), Tween 20 (Sigma-Aldrich, 
Germany), erythromycin 99.85% purity (Zhejiang Sanmen Hengkang Pharmaceutical Co., 
Ltd., China), chromatographically pure acetonitrile (Merck, Germany), disodium phosphate 
(Merck, Germany) were used. Purified water, double distilled water, and other reagents that 
conform to the quality requirements of the 10th Romanian Pharmacopoeia were used in pre-
paring microemulsions and in the quantitative analysis.
2.2. Methods
2.2.1. Determination of the ternary phase diagram and preparation of microemulsions
In the studied systems, we used lipophilic phase at 1:1 ratio mixture of avocado oil and isopropyl 
myristate. The surfactant and cosurfactant of the systems were consequently Tween 20 and also a 
Properties and Uses of Microemulsions18
1:1 ratio mixture of Tween 20/PEG 400. All formulations contained purified water as hydrophilic 
phase. The diagrams were built according to the method described by Fanun [12, 13].
2.2.1.1. Parameters involved in the physicochemical characterization of the microemulsions
Electrical conductivity (σ)—determined with Metrohm 712 conductometer (Herisau, Switzerland) 
with graphite electrode at room temperature (25 ± 2°C). The conductometric cell was calibrated 
with standard KCl solution.
Rheological behavior—the dynamic viscosity (η) was determined by rotational rheoviscosi-
timeter Rheolab MC120 (Stuttgart, Germany).
pH measurement—was performed using Thermo Orion pH meter (Thermo Fisher, Florida, USA).
Fourier transform infrared spectroscopy (FT-IR spectroscopy)—was done on a Vertex 70 
FT-IR spectrophotometer (Bruker, Germany), through spectra measurement of each sam-
ple and respectively of the raw materials involved. The obtained spectra were compared 
standard spectra presented in the literature. All measurements were performed three times 
at room temperature (25 ± 2°C), with the results expressed as a mean of three determina-
tions (± SD).
2.2.2. Preparation of microemulsions with avocado oil and erythromycin
Six microemulsion formulations were investigated. They were denoted as follows: three 
microemulsion formulations of the ternary phase diagram made with Tween 20 (F1—F3 
and 3 formulae (F4—F6) of the diagram in which the surfactant:cosurfactant Tween 20:PEG 
400 in the ratio of 1:1 was used. The formulations were selected from the regions of micro-
emulsion formation based on the ternary phase diagrams, as shown in Figures 1 and 2, 
respectively. They were used within 24 h after preparation. Microemulsions were prepared 
by gentle warming and stirring of the oil phase, by adding the surfactant based on the ter-
nary phase diagram and finally by including the aqueous phase, dropwise and with stirring 
at 200 rpm. Microemulsions were left at room temperature for 24 h, after which they were 
tested.
2.2.2.1. Quality control of microemulsions with erythromycin and avocado oil
Assessment of physical, chemical, and tactile properties—sensory properties of microemul-
sions, spreading ability, the emollient effect right after use (softness) and consistency were 
assessed in 10 volunteer patients, who rated products from 1 to 100 according to their satisfac-
tion level, following international guidelines on testing of cosmetics [14, 15].
Evaluation of transepidermal water loss (TEWL) measurement—the measurements were per-
formed using Tewameter TM 210 (Courage & Khazaka, Germany) on groups of six people, 
aged between 20 and 35 years. The epidermal water loss was measured immediately after 
applying the emulsion on the anterior surface of the palm (an area exposed to air, with a low 
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Figure 1. Ternary phase diagrams of the system avocado oil: IPM—Tween 20—water.
Figure 2. Ternary phase diagrams of the system avocado oil/IPM—Tween 20/PEG 400—water.
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density of sebaceous glands). This was considered the starting point of measurements, and 
it was followed by successive measurements at 30-min intervals for 2 hours [16]. The experi-
ment was carried out for three consecutive days, and the results were expressed as the mean 
of these three measurements.
Measurement of erythromycin (ER) content in avocado oil-based microemulsions—the mea-
surement of ER content in microemulsions was made by using HPLC method developed 
and validated in-house [17]. Working method: 0.50 g of sample (F1, F2, F3, F4, F5, And F6) is 
dissolved separately in 25 mL of the mobile phase, dispersed at warm temperatures for about 
5 min by magnetic stirring, and diluted to 10 mL with water. The resulting solution is centri-
fuged and filtered through a 0.45 μm filter and chromatographed.
2.2.3. Evaluation of in vitro and ex vivo release of erythromycin in avocado oil-based 
microemulsions
An in vitro dissolution test was carried out in a Franz cell with a diameter of 2.5 cm and the 
volume of the acceptor compartment of 15 mL, based on the following protocol: dissolution 
medium: phosphate buffer pH 7.4; mass of the sample: 0.5 g was processed for each studied 
formulation; cellulose membrane with a pore size of Ø = 45 μm (Millipore, Merck Germany); 
temperature: 37 ± 0.2°C; collection interval: 30 min, 1 h, 2 h, 3 h, 4 h, 5 h, and 6 h; an environ-
ment volume of 0.5 mL was harvested at each interval, and it was replaced with fresh medium; 
speed: 100 rpm.
An ex vivo dissolution test was carried out under similar conditions and the abdominal skin 
of female Wistar rats, weighing 200–250 g, was used as biological membrane. After harvest-
ing, hair and adipose tissue were removed from the fraction of the skin and put into a buffer 
system pH 7.4 for 24 h prior to testing. The collected samples were chromatographed, and 
erythromycin spectrum was recorded at a wavelength λ = 200 nm.
2.2.4. Measurement of the permeability coefficient of erythromycin in avocado oil-based 
microemulsions
The permeation rate of the substance in the stationary phase was measured from the slope, 
and the intercept was measured on the abscissa of the linear portion of the curves of the 
cumulative amount of drug substance that permeated with respect to time. The permeability 
coefficient was calculated according to Eq. (1):
   
  K 
p




—permeability coefficient (cm/h); J—permeation rate of the drug substance or stationary 
phase flow (μg/h); C—concentration in the donor compartment (μg/mL); A—contact surface 
area (cm2) [18].
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3. Results and discussion
Figures 1 and 2 display the ternary phase diagrams of the systems obtained with Tween 20 
and Tween 20/PEG 400 (1:1), respectively. The analysis of these diagrams showed no signifi-
cant differences of the microemulsion zones.
3.1. Physicochemical characterization of microemulsions
Stability assessment was done on six microemulsion formulations selected from the ternary 
phase diagram built with Tween 20 (1A, 1B, and 1C) and three formulations (2A, 2B, and 
2C) selected from the diagram with Tween 20/PEG 400 as surfactant/cosurfactant (1:1 ratio). 
Formulations were selected on the dilution line 7 of the ternary phase diagrams and contained 
5–15% lipophilic phase, with the results shown in Table 1.
The electrical conductivity of the analyzed microemulsions increases proportionally with the 
concentration of the hydrophilic phase of the system. The viscosity values indicate a newto-
nian behavior and a pH value close to the physiological one.
The FTIR spectra of the samples prepared by the two methods are shown in Figures 3a and 4a.
The FTIR spectra recorded for the raw excipients used for the preparation of microemulsions 
compiled with the reference spectra were presented in the literature [19]. Essentially, the FTIR 
spectra recorded for the microemulsion samples appear as a combination of the characteristic 
spectrum of avocado and that of the other three oily excipients. Regarding the resemblance 
with the spectra recorded for avocado oil, some spectral differences are obvious. First, a very 
intense and broad band is observed in the spectral range 3100–3700 cm−1, which is the nor-
mal range of adsorption for aliphatic hydroxyl group, and it is associated with the water 
content of the sample. Indeed, this band becomes more intense as the amount of water used 
in the formulation increases. Secondly, few differences can be noticed in the spectral range 
2750–3050 cm−1 also in the case of formulations encoded 1A, 1B, and 1C (shown in Figure 3b) 
and for those encoded as 2A, 2B, and 2C (shown in Figure 4b). In this area, it is notable the 




σ (mS/cm) (± SD)
Dynamic viscosity η 
(mPa·s) (± SD)
pH (± SD)
1A 5.00 11.98 (±1.21) 40.25 (±0.87) 5.02 (±0.84)
1B 10.00 13.86 (±1.08) 36.11 (±2.01) 5.19 (±0.54)
1C 15.00 17.51 (±0.94) 33.32 (±1.58) 5.21 (±0.60)
2A 5.00 20.50 (±1.42) 58.50 (±1.74) 5.80 (±0.63)
2B 10.00 25.35 (±0.91) 55.01 (±1.01) 5.11 (±0.41)
2C 15.00 29.39 (±1.92) 53.32 (±1.81) 5.35 (±0.31)
Table 1. Physicochemical parameters of microemulsions with avocado oil.
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fact that the band at 3009 cm−1 assigned to C-H stretching vibration of the cis-double bond 
disappears, while a decrease of the intensity of the band at 2852 cm−1 with the formation of a 
new band at 2874 cm−1. The band at 2852 cm−1 is usually assigned to symmetric and asymmet-
ric stretching vibration of the aliphatic—CH
2
 group, and that from 2874 cm−1 corresponds to 
symmetric and asymmetric stretching vibration of the aliphatic—CH
3
 group. These observa-
tions are supported also by the spectral changes in the region C=O region (1746 cm−1) as it can 
be seen in Figures 3c and 4c, respectively. Here, the study shows a shift of this band toward 
lower wavenumbers (1733 cm−1). This may happen due to the formation of saturated aldehyde 
functional groups or other secondary products during the heating process. These results are 
in accordance with observations made by other authors on the FTIR study of edible oils [20]. 
Finally, a new band is observed at 1643 cm−1. This band is associated with the bending vibra-
tions of the covalent bond in water molecules. Its intensity increases with the amount of water 
used in the formulation (see Figures 3c and 4c).
In the next phase of the study, these six formulations of avocado oil-based microemulsions 
were used as a vehicle for incorporating erythromycin in order to develop dermal prepara-
tions as microemulsions with erythromycin for topical administration.
Figure 3. (a) FTIR spectra recorded for microemulsion samples 1A, 1B, 1C, and raw materials avocado oil (UAV), 
isopropyl miristate (IPM), Tween 20 (T20); (b) FTIR spectra recorded for samples 1A, 1B, 1C, and avocado oil in the 
2700–3050 cm−1 spectral range; (c) FTIR spectra recorded for samples 1A, 1B, 1C, and avocado oil in the 1550–1800 cm−1 
spectral range.
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The analysis of sensory properties showed that microemulsions prepared with a mixture Tween 
20:PEG 400 as a surfactant had the best moisturizing and spreading properties (Figure 5).
This feature can be attributed to the presence of PEG 400 in the formulation, as it has a mois-
turizing effect on the skin. Although all microemulsion formulations were evaluated with a 
maximum score of 100 for the aspect, F1 and F3 formulations with the lowest percentage of 
the aqueous phase had the lowest score for spreading, as a greasy feeling was reported.
The TEWL measurement had the best values for the series of microemulsions prepared with 
the surfactant system Tween 20:PEG 400, as shown in Figure 6.
In order to assess the ER content of the studied microemulsion formulations, we compared 
the results with data from the monograph Emulsiones and Unguenta in the 10th Romanian 
Pharmacopoeia that admits a deviation of ±3% from the declared value for products contain-
ing 0.5% and more than 0.5% of active ingredient. The results shown in Table 2 suggest a 
uniform distribution of ER in the studied microemulsions, with a content of active ingredient 
ranging from 97.24 to 103.11%. These values conform to the standards of the 10th Romanian 
Pharmacopoeia [21].
Figure 4. (a) FTIR Spectra recorded for microemulsion samples 2A, 2B, 2C, and raw materials avocado oil (UAV), 
isopropyl miristate (IPM), Tween 20 (T20); (b) FTIR spectra recorded for samples 2A, 2B, 2C, and avocado oil in the 
2700–3050 cm−1 spectral range; (c) FTIR spectra recorded for samples 2A, 2B, 2C, and avocado oil in the 1550–1800 cm−1 
spectral range.
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Figure 5. Representation of the sensory properties of avocado oil-based microemulsions with erythromycin.
Figure 6. Representation of the TEWL measurement of avocado oil-based microemulsions with erythromycin.
Formulation The ER content (%)
F1 101.13 ± 0.54
F2 99.25 ± 0.71
F3 97.24 ± 1.04
F4 99.85 ± 0.96
F5 103.11 ± 0.46
F6 100.53 ± 0.87
Table 2. The content of the active ingredient in avocado oil-based microemulsions with erythromycin.
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The results of the in vitro and ex vivo ER release tests in avocado oil-based microemulsions are 
shown in Figures 7 and 8.
The results of the in vitro release through the synthetic membrane and ex vivo release through 
the biological membrane showed an unsatisfactory release of ER during the 6 hours of the study. 
Cumulative analysis of data suggests that F1-F3 formulations prepared with the Tween 20 sur-
factant had a slightly accelerated release rate within the first 2 hours of testing, after which the 
concentration of ER remains at a plateau level. We have found that F3 and F6 formulations that 
Figure 7. Cumulative kinetic profile of in vitro release of ER in avocado oil-based microemulsions.
Figure 8. Cumulative kinetic profile of ex vivo release of ER in avocado oil-based microemulsions.
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had the highest water content showed the highest percentage of release both in testing through 
biological membrane (F3 = 11.90%, and F6 = 18.18%) and in testing through synthetic membrane 
(F3 = 22.90 and 35.18%, respectively). F4-F6 formulations prepared with the cosurfactant system 
Tween 20:PEG 400 showed the highest percentage of ER release, ranging from 26.98 to 35.18% for 
the in vitro test and from 13.45 to 18.18% for the ex vivo test. This low percentage of release can 
be attributed to possible interactions between erythromycin and certain substances found in the 
microemulsion formulations, to ER insolubility in the dissolution medium, and to the large size 
of the erythromycin molecule.
Formulations prepared with the cosolvent system Tween 20:PEG 400 had the best coefficient 
of penetration, due to the presence of PEG 400 in the formulation (Table 3).
4. Conclusions
Microemulsions prepared with the surfactant system Tween 20:PEG 400 had the best sensory 
properties and the best transepidermal water loss measurement. ER was evenly distributed 
in the studied microemulsions that had a content of active ingredient ranging from 97.24 to 
103.11%. The results of the in vitro release tests through synthetic membrane and the results of 
the ex vivo release tests through biological membrane showed an ER release of less than 40%. 






 × 10−6 (cm/h)
Synthetic membrane (in vitro)
F1 30.4559 ± 7.2197 7115.86
F2 30.3371 ± 7.5029 7561.58
F3 25.0658 ± 7.7158 5424.43
F4 30.3625 ± 7.7720 7882.27
F5 28.2829 ± 7.7888 6926.99
F6 26.9587 ± 7.4907 6156.37
Biological membrane (ex vivo)
F1 25.0234 ± 7.1224 5181.90
F2 26.8229 ± 7.3379 5922.48
F3 25.3714 ± 7.3734 5466.80
F4 26.6616 ± 7.1809 5839.17
F5 25.0998 ± 7.2846 5387.38
F6 25.2441 ± 7.5083 5465.27
Table 3. Parameters specific to ER permeation in avocado oil-based microemulsions.
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est percentage of ER release, ranging from 26.98 to 35.18% for the in vitro test and from 13.45 
to 18.18% for the ex vivo test. The permeation degree of erythromycin was influenced by the 
presence of PEG 400, which led to a significant increase in this parameter.
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